Targeting growth factors and angiogenesis; using small molecules in malignancy

Author： Wanebo Harold   Argiris Athanassios   Bergsland Emily   Agarwala Sanjiv   Rugo Hope  

Publisher： Springer Publishing Company

ISSN： 0167-7659

Source： Cancer and Metastasis Reviews, Vol.25, Iss.2, 2006-06, pp. : 279-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Hedgehog Signaling Pathway with Small Molecules

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 5, 2006-09 ,pp. : 445-449

Bentham Science Publishers

Access to resources Recommend Favorite

Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism

By    

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2449-2458

Spandidos Publications

Access to resources Recommend Favorite

Targeting Angiogenesis in Ovarian Carcinoma

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 188-202

Bentham Science Publishers

Access to resources Recommend Favorite

Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma

By                

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1019-1026

Spandidos Publications

Access to resources Recommend Favorite

Widdrol, a sesquiterpene isolated from Juniperus chinensis, inhibits angiogenesis by targeting vascular endothelial growth factor receptor 2 signaling

By                

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1178-1184

Spandidos Publications

Access to resources Recommend Favorite